The DOI matches its Crossref record.
Rituximab Therapy for Acute Humoral Rejection After Kidney Transplantation
Abstract
A pilot study was performed on eight consecutive renal-transplant (RT) patients presenting with acute humoral rejection (AHR) to assess the efficacy of monoclonal anti-B cell antibodies, such as rituximab (375 mg/m weekly) for 3 to 5 consecutive weeks, in addition to plasma exchange (PE), steroids, mycophenolate mofetil, and tacrolimus. AHR was associated with increased serum creatinine, the appearance of donor-specific alloantibodies (DSA), and the presence of C4d in a transplant biopsy. After a follow-up of 10 months (range 7-23), patient and graft survivals were 100% and 75%, respectively. Renal function improved in six cases in which serum creatinine decreased from 297+/-140 to 156+/-53 micromol/L (P=0.015); graft loss occurred in two cases; and four patients had infectious complications. At last follow-up, DSA had disappeared or decreased in four cases. Rituximab therapy, in addition to PE, might be of benefit for RT patients presenting with AHR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C., Charron, D., Glotz, D., & Suberbielle-Boissel, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101065 · Cited by 789
Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
Vo, A. A., Lukovsky, M., Toyoda, M., Wang, J., Reinsmoen, N. L., Lai, C.-H., Peng, A., Villicana, R., & Jordan, S. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707894 · Cited by 692
Antibody-mediated vascular rejection of kidney allografts: a population-based study
Lefaucheur, C., Loupy, A., Vernerey, D., Duong-Van-Huyen, J.-P., Suberbielle, C., Anglicheau, D., Vérine, J., Beuscart, T., Nochy, D., Bruneval, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61265-3 · Cited by 340
Mechanism of cellular rejection in transplantation
Ingulli, E. (2010) · Pediatric Nephrology · doi:10.1007/s00467-008-1020-x · Cited by 313
Lefaucheur, C., Nochy, D., Andrade, J., Verine, J., Gautreau, C., Charron, D., Hill, G. S., Glotz, D., & Suberbielle-Boissel, C. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02591.x · Cited by 291
Metadata
- Authors
- Faguer, S., Kamar, N., Guilbeaud-Frugier, C., Fort, M., Modesto, A., Mari, A., Ribes, D., Cointault, O., Lavayssière, L., Guitard, J., Durand, D., & Rostaing, L.
- Venue
- Transplantation
- Published
- 2007-05-15
- Volume
- 83
- Issue
- 9
- Pages
- 1277-1280
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1987068568
- Cited by
- 211
- References
- 0
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rituximab Therapy for Acute Humoral Rejection After Kidney Transplantation. https://app.cochat.ai/papers/10.1097/01.tp.0000261113.30757.d1
- The paper
- Faguer, S., Kamar, N., Guilbeaud-Frugier, C., Fort, M., Modesto, A., Mari, A., Ribes, D., Cointault, O., Lavayssière, L., Guitard, J., Durand, D., & Rostaing, L. (2007). Rituximab Therapy for Acute Humoral Rejection After Kidney Transplantation. Transplantation. https://doi.org/10.1097/01.tp.0000261113.30757.d1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.